Apply

Ready to go for it?

AI Apply speeds things up—apply directly if you prefer.

FREE ACCESS
5,000–10,000 jobs/day
JobTailor Logo

See all jobs on JobTailor

Search thousands of fresh jobs every day.

Discover
  • Fresh listings
  • Fast filters
  • No subscription required
Create a free account and start exploring right away.
Biogen

Global Medical Director, Rare Disease – SMA Medical Education

Biogen

Global Medical Director developing medical education strategies for Biogen's SMA portfolio. Leading collaborations across clinical, commercial, and evidence teams to optimize treatment practices.

Posted 8/1/2026full-timeCambridge • Massachusetts • 🇺🇸 United StatesLead💰 $225,000 - $310,000 per yearWebsite

Core Competencies

Role fit
Core Competencies

Use this summary to align your resume positioning with the role.

Demonstrates expertise in leading medical education strategies and evidence generation for the SMA portfolio, with a strong focus on biomarker development and global regulatory compliance. Proven ability to engage with stakeholders and drive scientific narratives across diverse medical platforms.

Highest-signal resume keywords
Medical Education DevelopmentEvidence Generation StrategyBiomarker StrategyGlobal Regulatory KnowledgeRare Disease Expertise

ATS Keywords

Tailor your resume
Applicant Tracking System Keywords

Tip: use these terms in your resume and cover letter to boost ATS matches.

Hard Skills
Clinical Development OversightPublication PlanningScientific PositioningData PresentationMedical Review
Soft Skills
Team LeadershipStakeholder EngagementCoachingCollaboration
Tools & Technologies
Digital Medical SolutionsMedical Information Systems
Certifications & Qualifications
MDPhDPharmD
Industry Keywords
SMANeuromuscular DiseaseGlobal Medical AffairsClinical PracticeScientific Narratives

About the role

Key responsibilities & impact
  • Lead the long-range planning, development and execution of the Global SMA medical education strategy, tactics, and budget, advancing critical scientific narratives across regions and aligning with Biogen's Global Medical Plan and portfolio priorities.
  • Serve as the Global medical expert for the SMA portfolio, guiding lifecycle management and evidence strategy across the treatment journey.
  • Lead publication planning, KME/scientific engagement strategy and education plans for the SMA franchise, shaping treatment optimization and standard-of-care narratives ahead of evolving clinical practice.
  • Provide medical oversight and direction across clinical development programs and lead scientific positioning and strategy.
  • Own the neurofilament light chain (NfL) narrative and biomarker positioning, driving alignment across initiatives, functions, and regions, and resolving inconsistencies in the scientific story.
  • Partner with Evidence Generation Medical Director on the global SMA evidence generation strategy, including real-world evidence, biomarker development, and registrational study support, in close collaboration and alignment with regional clinical experts and cross-functional partners.
  • Present data at global medical affairs events, including advisory boards, trainings, congresses, and medical education events; build and nurture relationships with external stakeholders (HCPs, healthcare institutions, advocacy groups) across the global SMA therapeutic landscape.
  • Serve as the global medical contact for key functions/stakeholders (e.g., Clinical Development, PDC, regional/ICOE medical teams, Commercial, Market Access, Legal/Compliance, Value & Evidence Generation) and as global medical lead for aligning processes, decision making, medical tactics, and metrics through a robust operating rhythm.
  • Provide medical review and direction across publications and scientific communications (abstracts, posters, manuscripts), Medical Information (including complex/non-standard escalations), and affiliate/regional support requests; reinforce and train governance processes for scientific narrative, publication content, and agency involvement.
  • Lead end-to-end planning and content development for global SMA medical symposia (e.g., the WMS Medical Symposium), including speaker engagement, contracting, and coordination with regional medical teams and cross-functional partners.
  • Lead medical training strategy and planning tied to congress readouts, new manuscript data, and key scientific topics, including delivery of training materials and support for related Q&A; contribute to development/adaptation of medical materials (presentations, briefs, talking points) per review requirements.
  • Co-lead recurring cross-functional medical forums, including a monthly meeting to align global SMA medical teams and a quarterly insights forum to synthesize medical insights and inform planning.
  • Lead from where you are, coach each other, creating a positive team climate in alignment with Biogen's culture.

Requirements

What you’ll need
  • MD, PhD, PharmD or comparable advanced degree
  • Minimum of 8 years of pharmaceutical industry experience, preferably with prior work in regional/global roles.
  • Substitution of industry work with relevant clinical practice experience in neuromuscular or rare disease may be considered.
  • Relevant experience in Rare Disease required (preferably SMA and/or neuromuscular disease)
  • Experience in developing medical education, evidence generation required
  • Experience and expertise with biomarker strategy, digital medical solutions, processes, and systems
  • Strong working knowledge of global regulations as relevant to Medical Affairs

Benefits

Comp & perks
  • Medical, Dental, Vision, & Life insurances
  • Fitness & Wellness programs including a fitness reimbursement
  • Short- and Long-Term Disability insurance
  • A minimum of 15 days of paid vacation and an additional end-of-year shutdown time off (Dec 26-Dec 31)
  • Up to 12 company paid holidays + 3 paid days off for Personal Significance
  • 80 hours of sick time per calendar year
  • Paid Maternity and Parental Leave benefit
  • 401(k) program participation with company matched contributions
  • Employee stock purchase plan
  • Tuition reimbursement of up to $10,000 per calendar year
  • Employee Resource Groups participation